Literature DB >> 16828973

Cell signaling pathways engaged by KSHV.

Annika Järviluoma1, Päivi M Ojala.   

Abstract

Kaposi's sarcoma herpesvirus (KSHV) is the eighth human herpesvirus discovered in 1994 from Kaposi's sarcoma lesion of an AIDS patient. The strong molecular and epidemiological links associating KSHV with Kaposi's sarcoma and certain lymphoproliferative disorders indicate that KSHV is required for the development of these malignancies. Although KSHV is equipped to manipulate and deregulate several cellular signaling pathways, it is not yet understood how this leads to cell transformation. Profound understanding of the interplay of viral and cellular factors in KSHV-infected cells will provide valuable information on the mechanisms of viral tumorigenesis and enable development of efficient targeted therapies for virus-induced cancers. This review focuses on the cellular signaling pathways that KSHV gene products impinge on and discusses their putative contribution to tumorigenesis.

Entities:  

Mesh:

Year:  2006        PMID: 16828973     DOI: 10.1016/j.bbcan.2006.05.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  26 in total

Review 1.  Viruses and human cancer: from detection to causality.

Authors:  Ronit Sarid; Shou-Jiang Gao
Journal:  Cancer Lett       Date:  2010-10-23       Impact factor: 8.679

2.  Kaposi's sarcoma-associated herpesvirus K-cyclin interacts with Cdk9 and stimulates Cdk9-mediated phosphorylation of p53 tumor suppressor.

Authors:  Pei-Ching Chang; Mengtao Li
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

3.  Dysregulation of KSHV replication by extracts from Carthamus tinctorius L.

Authors:  Han Lee; Hyosun Cho; Myoungki Son; Gi-Ho Sung; Taeho Lee; Sang-Won Lee; Yong Woo Jung; Yu Su Shin; Hyojeung Kang
Journal:  J Microbiol       Date:  2013-08-30       Impact factor: 3.422

4.  Guanylate-Binding Protein 1 Inhibits Nuclear Delivery of Kaposi's Sarcoma-Associated Herpesvirus Virions by Disrupting Formation of Actin Filament.

Authors:  Zhe Zou; Zhihua Meng; Chao Ma; Deguang Liang; Rui Sun; Ke Lan
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

5.  Tousled-like kinases modulate reactivation of gammaherpesviruses from latency.

Authors:  Patrick J Dillon; Sean M Gregory; Kristen Tamburro; Marcia K Sanders; Gary L Johnson; Nancy Raab-Traub; Dirk P Dittmer; Blossom Damania
Journal:  Cell Host Microbe       Date:  2013-02-13       Impact factor: 21.023

Review 6.  Cell cycle regulation during viral infection.

Authors:  Sumedha Bagga; Michael J Bouchard
Journal:  Methods Mol Biol       Date:  2014

7.  Development of an ORF45-Derived Peptide To Inhibit the Sustained RSK Activation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Xiaojuan Li; Lu Huang; Yunjun Xiao; Xiangyang Yao; Xubing Long; Fanxiu Zhu; Ersheng Kuang
Journal:  J Virol       Date:  2019-05-01       Impact factor: 5.103

8.  Cyclin K and cyclin D1b are oncogenic in myeloma cells.

Authors:  Véronique Marsaud; Guergana Tchakarska; Geoffroy Andrieux; Jian-Miao Liu; Doulaye Dembele; Bernard Jost; Joanna Wdzieczak-Bakala; Jack-Michel Renoir; Brigitte Sola
Journal:  Mol Cancer       Date:  2010-05-10       Impact factor: 27.401

9.  Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.

Authors:  Grzegorz Sarek; Annika Järviluoma; Henna M Moore; Sari Tojkander; Salla Vartia; Peter Biberfeld; Marikki Laiho; Päivi M Ojala
Journal:  PLoS Pathog       Date:  2010-03-19       Impact factor: 6.823

10.  Distinct roles for extracellular signal-regulated kinase 1 (ERK1) and ERK2 in the structure and production of a primate gammaherpesvirus.

Authors:  Evonne N Woodson; Dean H Kedes
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.